{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:50:04Z","timestamp":1755798604391,"version":"3.44.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,19]]},"DOI":"10.7759\/cureus.90470","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T11:45:09Z","timestamp":1755603909000},"source":"Crossref","is-referenced-by-count":0,"title":["Idiopathic Hypereosinophilic Syndrome Presenting As Eosinophilic Ascites and Pleural Effusion in an Elderly Male: A Rare Clinical Manifestation"],"prefix":"10.7759","author":[{"given":"Calvin","family":"Jose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas V","family":"Pulickal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issac","family":"Georgy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Alex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avaroth","family":"Krishnadas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1097\/00005792-197501000-00001","article-title":"The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature","volume":"54","author":"Chusid MJ","year":"1975","unstructured":"Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore). 1975, 54:1-27.","journal-title":"Medicine (Baltimore)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent P","year":"2012","unstructured":"Valent P, Klion AD, Horny HP, et al.. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol. 2012, 130:607-612.e9. 10.1016\/j.jaci.2012.02.019","journal-title":"J Allergy Clin Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.03.042","article-title":"Refining the definition of hypereosinophilic syndrome","volume":"126","author":"Simon HU","year":"2010","unstructured":"Simon HU, Rothenberg ME, Bochner BS, et al.. Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol. 2010, 126:45-9. 10.1016\/j.jaci.2010.03.042","journal-title":"J Allergy Clin Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-551614","article-title":"How I treat hypereosinophilic syndromes","volume":"126","author":"Klion AD","year":"2015","unstructured":"Klion AD. How I treat hypereosinophilic syndromes. Blood. 2015, 126:1069-77. 10.1182\/blood-2014-11-551614","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.09.022","article-title":"Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy","volume":"124","author":"Ogbogu PU","year":"2009","unstructured":"Ogbogu PU, Bochner BS, Butterfield JH, et al.. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol. 2009, 124:1319-25.e3. 10.1016\/j.jaci.2009.09.022","journal-title":"J Allergy Clin Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000225646.69813.f0","article-title":"Eosinophilic ascites as the first sign of idiopathic hypereosinophilic syndrome in childhood","volume":"41","author":"de Carpi JM","year":"2007","unstructured":"de Carpi JM, Rives S, Prada F, Varea V. Eosinophilic ascites as the first sign of idiopathic hypereosinophilic syndrome in childhood. J Clin Gastroenterol. 2007, 41:864-5. 10.1097\/01.mcg.0000225646.69813.f0","journal-title":"J Clin Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.12890\/2017_000586","article-title":"Subserous eosinophilic gastroenteritis: a rare cause of ascites","volume":"4","author":"Ferreira AA","year":"2017","unstructured":"Ferreira AA, Barbosa SM, Oliveira S, Ramada J, Silva A. Subserous eosinophilic gastroenteritis: a rare cause of ascites. Eur J Case Rep Intern Med. 2017, 4:000586. 10.12890\/2017_000586","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref8","article-title":"A review of eosinophilic gastroenteritis","volume":"98","author":"Baig MA","year":"2006","unstructured":"Baig MA, Qadir A, Rasheed J. A review of eosinophilic gastroenteritis. J Natl Med Assoc. 2006, 98:1616-9.","journal-title":"J Natl Med Assoc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.010421","article-title":"Hypereosinophilic syndrome variants: diagnostic and therapeutic considerations","volume":"94","author":"Roufosse F","year":"2009","unstructured":"Roufosse F. Hypereosinophilic syndrome variants: diagnostic and therapeutic considerations. Haematologica. 2009, 94:1188-93. 10.3324\/haematol.2009.010421","journal-title":"Haematologica"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools J","year":"2003","unstructured":"Cools J, DeAngelo DJ, Gotlib J, et al.. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003, 348:1201-14. 10.1056\/NEJMoa025217","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2023.07.012","article-title":"Hypereosinophilic syndrome and T-cell lymphoma: which comes first?","volume":"114","author":"Meruelo Ruano M","year":"2023","unstructured":"Meruelo Ruano M, Gonz\u00e1lez Romero N, Lobato Izagirre A, Gainza Apraiz I. Hypereosinophilic syndrome and T-cell lymphoma: which comes first?. Actas Dermosifiliogr. 2023, 114:835-6. 10.1016\/j.ad.2023.07.012","journal-title":"Actas Dermosifiliogr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2008.005447","article-title":"T-cell abnormalities are present at high frequencies in patients with hypereosinophilic syndrome","volume":"94","author":"Helbig G","year":"2009","unstructured":"Helbig G, Wieczorkiewicz A, Dziaczkowska-Suszek J, Majewski M, Kyrcz-Krzemien S. T-cell abnormalities are present at high frequencies in patients with hypereosinophilic syndrome. Haematologica. 2009, 94:1236-41. 10.3324\/haematol.2008.005447","journal-title":"Haematologica"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2000.105712","article-title":"Mechanisms of eosinophil-associated inflammation","volume":"105","author":"Gleich GJ","year":"2000","unstructured":"Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol. 2000, 105:651-63. 10.1067\/mai.2000.105712","journal-title":"J Allergy Clin Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812185","article-title":"Benralizumab for PDGFRA-negative hypereosinophilic syndrome","volume":"380","author":"Kuang FL","year":"2019","unstructured":"Kuang FL, Legrand F, Makiya M, et al.. Benralizumab for PDGFRA-negative hypereosinophilic syndrome. N Engl J Med. 2019, 380:1336-46. 10.1056\/NEJMoa1812185","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.08.037","article-title":"Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a\u00a0phase III, randomized, placebo-controlled trial","volume":"146","author":"Roufosse F","year":"2020","unstructured":"Roufosse F, Kahn JE, Rothenberg ME, et al.. Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a\u00a0phase III, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2020, 146:1397-405. 10.1016\/j.jaci.2020.08.037","journal-title":"J Allergy Clin Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/388195-idiopathic-hypereosinophilic-syndrome-presenting-as-eosinophilic-ascites-and-pleural-effusion-in-an-elderly-male-a-rare-clinical-manifestation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T11:45:10Z","timestamp":1755603910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/388195-idiopathic-hypereosinophilic-syndrome-presenting-as-eosinophilic-ascites-and-pleural-effusion-in-an-elderly-male-a-rare-clinical-manifestation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.90470","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,8,19]]}}}